| Literature DB >> 35059614 |
Alexandra Molina García1, James H Cross1, Elizabeth J A Fitchett2, Kondwani Kawaza3, Uduak Okomo4, Naomi E Spotswood5, Msandeni Chiume3, Veronica Chinyere Ezeaka6, Grace Irimu7, Nahya Salim8, Elizabeth M Molyneux3, Joy E Lawn1.
Abstract
BACKGROUND: Health care-associated infections (HCAI) in neonatal units in low- and middle-income countries (LMIC) are a major cause of mortality. This scoping review aimed to synthesise published literature on infection prevention and care bundles addressing neonatal HCAI in LMICs and to construct a Classification Framework for their components (elements).Entities:
Keywords: 3 + I Framework, (1) Primary Prevention (2) Detection (3) Case Management + Implementation; ERIC, Expert Recommendations for Implementing Change; HCAI, Health Care-Associated Infections; LMIC, Low- and Middle-Income Countries; PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses; PRISMA-ScR, Preferred Reporting Items for Systematic Reviews and Meta-Analyses for Scoping Reviews; care bundles; health care-associated infections; infection prevention and control; low- and middle-income countries; neonatal units; scoping review
Year: 2022 PMID: 35059614 PMCID: PMC8760419 DOI: 10.1016/j.eclinm.2021.101259
Source DB: PubMed Journal: EClinicalMedicine ISSN: 2589-5370
Figure 1PRISMA flow diagram of study selection. Abbreviations: n = number of records; HCAI = health care-associated infections.
Characteristics of the 44 included studies.
| Author (Year) | Country | Aim of Study | Study Design | Level of INCU | Number of Care Bundles | Number of Bundle Elements | ||
|---|---|---|---|---|---|---|---|---|
| Arora | India | Evaluate the impact of management guidelines on neonatal morbidity and mortality of VLBW neonates | Uncontrolled, before-after | III | 3 | CL insertion bundle: 7 | ||
| Azab | Egypt | Evaluate the effectiveness of VAP prevention bundle on rates of neonatal VAP | Uncontrolled, before-after | III | 1 | 7 | ||
| Balla | India | Reduce neonatal CLABSI rates by 25% in three months and to sustain this over the next nine months | Uncontrolled, before-after | III | 1 | CL removal bundle: 2 | ||
| Hussain | Pakistan | Design a CLABSI prevention package to decrease CLABSI rates | Uncontrolled, before-after | III | 1 | CL maintenance bundle: 5 | ||
| Resende | Brazil | Reduce CLABSI rates using a care bundle | Uncontrolled, before-after | III | 1 | 5 | ||
| Resende | Brazil | Evaluate the impact of an evidence-based bundle in LOS incidence rates | Uncontrolled, before-after | III | 1 | 7 | ||
| Rosenthal | El Salvador, Mexico, The Philippines, and Tunisia | Evaluate the impact of INICC multidimensional infection control programme to reduce CLABSI | Uncontrolled, before-after | III | 1 | CL: 7 | ||
| Tran | Vietnam | Evaluate the impact of the EENC on clinical practices, NICU admissions, and adverse newborn outcomes | Uncontrolled, before-after | III | 1 | 8 | ||
| Wang | China | Evaluate the effectiveness and feasibility of a CL bundle guideline with a standard checklist in the prevention of PICC-related infections in VLBW infants | Uncontrolled, before-after | III | 2 | CL insertion bundle: 5 | ||
| No detection bundles in the studies | ||||||||
| Bouallègue-Godet | Tunisia | Report outbreak of | Retrospective, descriptive | III | 1 | 3 | ||
| Indarso | Indonesia | Report outbreak of | Retrospective, descriptive | NR | 1 | 5 | ||
| Jeena | South Africa | Report outbreak of | Retrospective, descriptive | III | 1 | 7 | ||
| Lithgow | Papua New Guinea | Report outbreak of | Retrospective, descriptive | NR | 1 | 4 | ||
| Moodley | South Africa | Report outbreak of | Retrospective, descriptive | III | 1 | 3 | ||
| Shanmuganathan | India | Report outbreak of | Retrospective, descriptive | III | 1 | 3 | ||
| Balla | India | Reduce neonatal CLABSI rates by 25% in three months and to sustain this over the next nine months | Uncontrolled, before-after | III | 1 | CL insertion bundle: 3 | ||
| Cavicchiolo | Mozambique | To assess the effectiveness of interventions in terms of reduction of the neonatal mortality rate | Uncontrolled, before-after | NR | 2 | Structural bundle: 3 | ||
| Gilbert | Brazil | Develop an educational package and evaluate its impact on a range of neonatal outcomes | ITS | III | 1 | 6 | ||
| Gill | The Philippines | Evaluate the effectiveness of a package of infection control interventions | Uncontrolled, before-after | III | 1 | 4 | ||
| Picheansathian | Thailand | Identify the impact of a promotion programme on hand hygiene practices and its effect on nosocomial infection rates | Uncontrolled, before-after | NR | 1 | 6 | ||
| Villegas | Costa Rica | Determine the BSI rate of a NICU | Uncontrolled, before-after | III | 1 | 2 | ||
| Agarwal | India | Evaluate the impact of simple interventions on neonatal mortality | Uncontrolled, before-after | III | 1 | 10 | ||
| Ahmed | Pakistan | Report outbreak of | Retrospective, descriptive | III | 1 | 7 | ||
| Ávila | Cuba | Report outbreak of | Retrospective, descriptive | NR | 1 | 7 | ||
| Balla | India | Reduce neonatal CLABSI rates by 25% in three months and to sustain this over the next nine months | Uncontrolled, before-after | III | 2 | Main bundle: 4 | ||
| Calil | Brazil | Evaluate the efficacy of measures to control colonisation and infection by multiresistant bacteria | Uncontrolled, before-after | III | 1 | 3 | ||
| Cavicchiolo | Mozambique | To assess the effectiveness of interventions in terms of reduction of the neonatal mortality rate | Uncontrolled, before-after | NR | 1 | Clinical bundle: 10 | ||
| Cetin | Turkey | Report outbreak of | Retrospective, analytical | III | 1 | 5 | ||
| Chakrabarti | India | Report outbreak of | Retrospective, analytical | III | 1 | 4 | ||
| Chen | China | Evaluate the efficacy of different measures in preventing ICI in preterm infants < 33 weeks | Uncontrolled, before-after | III | 1 | 6 | ||
| Grey | Guatemala | Report outbreak of | Retrospective, descriptive | III | 1 | 4 | ||
| Hosoglu | Turkey | Report outbreak of | Retrospective, analytical | III | 1 | 8 | ||
| Huang | China | Evaluate the efficacy of a bundle intervention on health care-associated MRSA infection | Uncontrolled, before-after | III | 1 | 6 | ||
| Hussain | Pakistan | Design a CLABSI prevention package to decrease CLABSI rates | Uncontrolled, before-after | III | 3 | Main bundle: 5 | ||
| Irfan | Pakistan | Report outbreak of MRSA | Retrospective, descriptive | II | 1 | 11 | ||
| Kulali | Turkey | Evaluate the effectiveness of bundled applications in the prevention of UVC-associated bloodstream infections | Uncontrolled, before-after | III | 1 | 7 | ||
| Landre-Peigne | Senegal | Evaluate the impact of a programme on the incidence of nosocomial bloodstream infections, neonatal mortality rates, the prevalence of drug-resistant strains and antimicrobial use | Uncontrolled, before-after | II | 1 | 4 | ||
| Mais | Lebanon | Evaluate the impact of quality improvement bundles on CLABSI rates | Uncontrolled, before-after | III | 1 | 3 | ||
| Miranda-Novales | Mexico | Report outbreak of | Retrospective, descriptive | III | 1 | 4 | ||
| Moore | Egypt | Report outbreak of | Retrospective, descriptive | III | 1 | 3 | ||
| Mshana | Tanzania | Report outbreak of a novel | Retrospective, descriptive | NR | 1 | 4 | ||
| Mwananyanda | Zambia | Evaluate the impact of an infection prevention control bundle on hospital-associated BSI and mortality | ITS | III | 1 | 5 | ||
| Narayan | Fiji | Report outbreak of | Retrospective, descriptive | III | 1 | 10 | ||
| Qi | China | Report outbreak of | Retrospective, descriptive | III | 1 | 6 | ||
| Rahim | Malaysia | Implement education-based interventions to contribute to a reduction in nosocomial infections | Uncontrolled, before-after | III | 1 | 3 | ||
| Rosenthal | Argentina, Colombia, India, Mexico, Morocco, Peru, Philippines, El Salvador, Tunisia, Turkey | Evaluate the impact of the INICC multidimensional infection control programme on the reduction of VAP | Uncontrolled, before-after | III | 1 | 11 | ||
| Rosenthal | El Salvador, Mexico, The Philippines, and Tunisia | Evaluate the impact of INICC multidimensional infection control programme to reduce CLABSI | Uncontrolled, before-after | III | 1 | Main bundle: 6 | ||
| Zhou | China | Evaluate the effectiveness of an intervention programme in decreasing neonatal VAP rate, neonatal mortality and the prevalence of drug-resistant strains | Uncontrolled, before-after | III | 1 | 8 | ||
| Zhou | China | Characterise CLABSI in a Chinese NICU | Uncontrolled, before-after | III | 1 | 5 | ||
Low- and middle-income countries where the included studies were performed as per World Bank definitions (2020).
Balla et al. contains four bundles in the following groups: two primary prevention, one implementation, and one composite.
Hussain et al. contains four bundles in the following groups: one primary prevention and three composite.
Rosenthal et al. contains two bundles in the following groups: one primary prevention and one composite.
Cavicchiolo et al. contains three bundles in the following groups: two implementation and one composite.
Abbreviations- BSI = bloodstream infections; CL = central line; CLABSI = central line-associated bloodstream infections; EENC = Early Essential Newborn Care; EPIQ = evidence-based practice for improving quality; ICI = invasive candida infections; INICC = International Nosocomial Infection Control Consortium; INCU = inpatient neonatal care units; ITS = interrupted time series; LOS = late-onset sepsis; MRSA = methicillin-resistant S. aureus; NICU = neonatal intensive care unit; NR = not reported; PICC = peripherally inserted central catheter; UVC = umbilical venous catheter; VAP = ventilator-associated pneumonia; VLBW = very low birth weight.
Figure 2Word cloud with the terminology used to name the care bundles. The world cloud visually represents the names used to describe care bundles depicted in different sizes based on the frequency of their use in the 44 included studies: the higher the frequency of a name, the bigger its appearance in the cloud. Frequencies of the names: Measures = 13 (30%); Bundle = 9 (21%); Quality Improvement = 5 (11%); Programme = 4 (9%); Package = 3 (7%); Multifaceted Intervention = 2 (5%); Precautions = 1 (2%); Strategies = 1 (2%); Practices = 1 (2%); Options = 1 (2%); Multidimensional Approach = 1 (2%); Response = 1 (2%); Intervention = 1 (2%); Interventions = 1 (2%).
Qualitative data summary findings of the 3 + I Classification Framework.
| Primary prevention | Elements aiming to avoid health care-associated infections in neonatal care units (e.g., promotion of kangaroo mother care or breastfeeding, reinforcement of the staff's hand hygiene). |
| Detection | Elements focused on secondary prevention such as the screening and surveillance of health care-associated infections in infected newborns admitted in inpatient neonatal care units (e.g., implementation and reinforcement of infection surveillance programmes). |
| Case management | Elements focused on tertiary prevention. They describe care of infected neonates or interventions to control the propagation of health care-associated infections in the neonatal units (e.g., cohorting of neonates, changes in antibiotic policy and stewardship, improvement to environmental and equipment disinfection protocols). |
| Implementation | Elements directed towards the methods of enhancing the adoption, implementation, or sustainability of interventions (e.g., provision of single use fluid vials or alcohol-based hand rub, conduct educational meetings on infection prevention and control measures, establishing audit and feedback mechanisms). |
| Neonate | Elements aimed directly at the neonate. |
| Staff | Elements aimed at the health care staff. |
| Caretaker | Elements focused on the caretakers of the admitted newborn patients. |
| Environment | Elements directed towards the surroundings of the neonate in the inpatient neonatal care units and its organisation. |
| Device | Elements tackling nosocomial infections acquired through medical equipment. |
| Screening | Elements that encompass the detection of disease outbreaks and their risk factors. |
| Epidemiological surveillance | Bundle elements focused on the collection, analysis, and monitoring of data on health care-associated infections in neonatal care units. |
| Antibiotic prescription | Elements aimed at implementing or improving antibiotic policy and stewardship of inpatient neonatal care settings. |
| Outbreak control | Elements focused on controlling infectious outbreaks detected in the inpatient neonatal care units. |
| Audit and feedback | Elements focused on collecting clinical performance data to share with neonatal health care staff and managers to monitor, evaluate, and modify their behaviour*. |
| Change physical structure and equipment | Bundle elements that evaluate the existing set-up of the neonatal wards and adapt their physical structure and/or equipment to improve the quality of care*. |
| Conduct educational meetings | Bundle elements that teach all the interested groups about the health care intervention implemented in the neonatal ward through meetings*. |
| Create or change credentialing and/or licensure standards | Elements aiming at creating or changing a system that certifies staff's skills in the health care intervention and/or grants the health care system or unit with a license to implement an intervention*. |
| Create new clinical teams | Interventions that change health care staff members to ensure that the health care intervention is delivered by incorporating new skills and work profiles to the team*. |
| Develop educational materials | Elements focused on the creation of unit protocols, guidelines, tools, manuals, or other materials to improve staff's training and understanding of the health care innovation*. |
| Organise clinician implementation team meetings | Bundle elements that establish meetings for the clinicians responsible for implementing the health care intervention to ensure a time for reflection on the implementation process and for sharing lessons learnt*. |
| Recruit, designate and train for leadership | Elements that enrol, assign, and train the leaders of the clinical innovation in the neonatal units*. |
| Remind clinicians | Elements directed at creating reminder systems to promote the use of or provide information on a health care intervention in the neonatal wards*. |
| Revise professional roles | Bundle elements aiming at reviewing and changing the job profiles and responsibilities of the neonatal health care staff*. |
Table describing the different groups (a) and subgroups (b) identified after performing the qualitative data analysis to construct the Classification Framework for care bundle elements. If bundle elements were coded with headings related to implementation strategies, these were grouped after the categories created by Powell and colleagues in the Expert Recommendations for Implementing Change (ERIC) study.Legend: *Adaptation of the category definitions proposed by Powell and colleagues in the Expert Recommendations for Implementing Change (ERIC) study to the neonatal care units.
Frequency of the 295 bundle elements according to the 3 + I Classification Framework.
| Element classification | Bundle classification | Total number of elements per row (%) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Type 1 – Primary Prevention | Type 2 -Detection | Type 3 - Case Management | Type 4 -Implementation | Type 5 - Composite | |||||
| 1. Neonate | 1.1. Feeding | 1 | ·· | ·· | ·· | 1 | 2 (1·6) | ||
| 1.2. Skin-to-skin contact | 1 | ·· | ·· | ·· | ·· | 1 (0·8) | |||
| 1.3. Skin disinfection | 4 | ·· | ·· | ·· | 3 | 7 (5·5) | |||
| 1.4. Drug prescription | 1 | ·· | ·· | ·· | 6 | 7 (5·5) | |||
| 1.5. Isolation | ·· | ·· | ·· | ·· | 1 | 1 (0·8) | |||
| 1.6. Reduction of handling | ·· | ·· | ·· | ·· | 1 | 1 (0·8) | |||
| 2. Staff | 2.1. HH | 10 | ·· | ·· | ·· | 8 | 18 (14·1) | ||
| 2.2. Use of protocols/policies | 1 | ·· | ·· | ·· | 1 | 2 (1·6) | |||
| 2.3. Organisation | ·· | ·· | ·· | ·· | 2 | 2 (1·6) | |||
| 2.4. Contact barrier precautions | 4 | ·· | ·· | ·· | 2 | 6 (4·7) | |||
| 3. Caretaker | 3.1. Empower mothers in routine care | ·· | ·· | ·· | ·· | 1 | 1 (0·8) | ||
| 4. Environment | 4.1. Areas & equipment disinfection | ·· | ·· | ·· | ·· | 3 | 3 (2·3) | ||
| 4.2. Waste disposal | ·· | ·· | ·· | ·· | 1 | 1 (0·8) | |||
| 4.3. General unit organisation | 1 | ·· | ·· | ·· | 4 | 5 (3·9) | |||
| 5. Device | 5.1. Catheter | 36 | ·· | ·· | ·· | 19 | 55 (42·9) | ||
| 5.2. Ventilator | 5 | ·· | ·· | ·· | 11 | 16 (12·5) | |||
| 1. Screening | 1.1. New screening programme | ·· | ·· | ·· | ·· | 2 | 2 (16·7) | ||
| 2. Epidemiological surveillance | 2.1. Implementation of new infection surveillance programme | ·· | ·· | ·· | ·· | 3 | 3 (25·0) | ||
| 2.2. Enhance existing surveillance programmes | ·· | ·· | ·· | ·· | 7 | 7 (58·3) | |||
| 1. Antibiotic prescription | 1.1. Antibiotic policy & stewardship | ·· | ·· | 1 | ·· | 8 | 9 (12·0) | ||
| 2. Outbreak control | 2.1. Neonate | 2.1.1 Skin disinfection | ·· | ·· | 1 | ·· | 1 | 2 (2·7) | |
| 2.1.2 Feeding | ·· | ·· | 1 | ·· | ·· | 1 (1·3) | |||
| 2.1.3 Drug prescription | ·· | ·· | 1 | ·· | ·· | 1 (1·3) | |||
| 2.1.4 Isolation | ·· | ·· | 2 | ·· | 3 | 5 (6·7) | |||
| 2.2. Staff | 2.2.1. HH | ·· | ·· | 4 | ·· | 4 | 8 (10·7) | ||
| 2.2.2. Use of protocols/policies | ·· | ·· | ·· | ·· | 4 | 4 (5·3) | |||
| 2.2.3. Organisation | ·· | ·· | ·· | ·· | 1 | 1 (1·3) | |||
| 2.2.4. Contact precautions | ·· | ·· | 3 | ·· | 4 | 7 (9·3) | |||
| 2.2.5. Treatment of staff | ·· | ·· | ·· | ·· | 1 | 1 (1·3) | |||
| 2.3. Environment | 2.3.1. Areas & equipment disinfection | ·· | ·· | 4 | ·· | 7 | 11 (14·7) | ||
| 2.3.2. General unit organisation | ·· | ·· | 7 | ·· | 17 | 24 (32·0) | |||
| 2.4. Device | 2.4.1. Catheter | ·· | ·· | ·· | ·· | 1 | 1 (1·3) | ||
| 1. Audit & feedback | ·· | ·· | ·· | 4 | 5 | 9 (11·3) | |||
| 2. Change physical structure & equipment | ·· | ·· | ·· | 12 | 8 | 20 (25·0) | |||
| 3. Conduct educational meetings | ·· | ·· | ·· | 10 | 25 | 35 (43·8) | |||
| 4. Create/change credentialing and/or licensure standards | ·· | ·· | ·· | 2 | 3 | 5 (6·3) | |||
| 5. Create new clinical teams | ·· | ·· | ·· | ·· | 1 | 1 (1·3) | |||
| 6. Develop educational materials | ·· | ·· | ·· | ·· | 3 | 3 (3·8) | |||
| 7. Organise clinician implementation team meetings | ·· | ·· | ·· | ·· | 1 | 1 (1·3) | |||
| 8. Recruit, designate & train for leadership | ·· | ·· | ·· | ·· | 1 | 1 (1·3) | |||
| 9. Remind clinicians | ·· | ·· | ·· | 1 | 1 | 2 (2·5) | |||
| 10. Revise professional roles | ·· | ·· | ·· | ·· | 3 | 3 (3·8) | |||
| ·· | ·· | ·· | |||||||
Legend: α No detection bundles in the studies. β Percentages are calculated using the total number of elements for each group as the denominator. γ Two devices were the target of all the bundle elements found in the literature: central line catheters and mechanical ventilators. No bundle elements were found for other medical devices. δ 305 bundle elements were identified in the included studies. However, only 295 of them were coded into the 3 + I Classification Framework because two elements could not be categorised due to a lack of detail to interpret their meaning and eight other elements were implemented exclusively in labour wards and not in neonatal wards (and therefore excluded). (··) is a zero value.
Abbreviations: HH = hand hygiene.
Figure 3Frequency of the groups of bundle elements (3a) and frequency of the types of infection prevention and care bundles (3b). Colour legend: Figure 3a: Salmon = primary prevention; Violet = detection; Burgundy = case management; Blue = implementation. Figure 3b: Red = Type 1 – primary prevention; Grey = Type 2 – detection; Green = Type 3 – case management; Dark blue = Type 4 – implementation; Yellow = Type 5 – composite. After the creation of the four groups of the 3 + I Classification Framework using the bundle elements (i.e., prevention, detection, case management and implementation, represented in Figure 3a with their frequencies), whole bundles were also categorised into groups, according to the types of elements each one was made of (e.g., if one bundle contained four primary prevention elements, the whole bundle was categorised in primary prevention -Type 1- bundles. If one bundle contained a mixture of prevention, detection, case management, or implementation elements then the whole bundle was categorised into the composite -Type 5- group bundle). These are represented in Figure 3b.